What the Brand Says About How These Medications May Work The brand's materials describe semaglutide as a medication that "may work through the GLP-1 pathway" and tirzepatide as one that "may work through both GIP and GLP-1 pathways." Per the official website, GLP-1-based treatment "may be considered as part of a broader provider-guided care plan for weight care," and the brand frames weight care generally as involving "a range of factors, including appetite signaling, metabolism, and overall health history" - not a single mechanism or a guaranteed outcome
In practice, small quantities of legitimate medications for personal use are generally allowed through, provided certain conditions are met
Its use for weight loss is a more recent application, with brand names like Wegovy, Saxenda, and Zepbound dominating markets in the current health landscape
Nice dr and consultant very well I like it Excellent consultation with proper explanation and good treatment Very sweet doctor and experienced
However, narrative reviews were excluded from this scoping review
